Cardiovascular Renal Metabolic

Watch time: 30m 1s (2 videos)
BI 764198 Reduces Proteinuria in FSGS Phase 2 Trial

Radcliffe CVRM

Study: 6 in 10 US Adults Eligible for CKM Drugs

Radcliffe CVRM

Ep 152: From Risk Factor to Treatment Target: The New Era of Cardiometabolic Medicine

Listen time: 38m 33s
Tirzepatide Cuts Cardiometabolic Risk in OSA, Obesity

Radcliffe CVRM

Ep 151: Cardiology's 2025 Year in Review with Dr Sukh Nijjer

Listen time: 1h 40m 44s

Broadcast

Cardiovascular Renal Metabolic

Guidelines & Statements
Targeting Residual Inflammatory Risk

Smeeta Sinha, Ramzi Y. J. Khamis, Daniel Bromage, et al

Watch time: 1h 3m 57s
Metabolic Factors Now Key Drivers of Heart Failure

Radcliffe Cardiology

High-Dose Flu Vaccine Reduces Hospitalisation in CKD

Radcliffe CVRM

Metabolome-Informed BMI Better Predicts CVRM Risk

Radcliffe CVRM

Primary Care Process Curbs Population Weight Gain

Radcliffe CVRM

Tirzepatide Noninferior to Dulaglutide for CV Events

Radcliffe CVRM

Nikolaus Marx, Azmee Ghazi, Ong Mei Lin, et al

Watch time: 54m 35s (2 videos)

Andrew JS Coats, Stefan Anker

James Burton, Clara Bonanad Lozano, Csaba Kovesdy, et al

Watch time: 1h 1m 16s (5 videos)
Ep 131: Beyond Weight Loss: GLP-1s as Cardioprotective Game-Changers in 2025

Listen time: 40m 45s

Watch time: 30m 1s (2 videos)
Ep 145: From NAFLD to MASLD: Unveiling the Cardiovascular Impact of Metabolic Liver Disease

Listen time: 30m 36s

Shubh K Patel, Hwee Teoh, Ahreni Saunthar, et al

Read time: 24m 34s
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice

Michelle O'Donoghue

Watch time: 5m 1s
EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 5m 20s

Emily Morris, Oliver J Rider

Read time: 19m 30s
EP 111: ACC 24 in Review With Dr Vallabhajosyula: 5 Trials That Will Change Your Practice

Listen time: 1h 11m 26s

David Tak Wai Lui, Junya Ako, Jamshed Dalal, et al

Read time: 20m 26s

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s

Stefan Anker, Giuseppe Rosano, Javier de Juan Bagudá, et al

Watch time: 15h 45m 20s (18 videos)
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

James Burton, Shelley Zieroth, Clara Bonanad Lozano, et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, Kerri L Cavanaugh, John Spertus, et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s

Media

Watch time: 30m 1s (2 videos)

Paresh Parmar, Yassir Javaid, Nina Barnett

Watch time: 42m 25s (4 videos)

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
New Horizons in Obesity Management 2026

Angela Fitch, Richard Hobbs, Nikolaus Marx

Broadcast

Cardiovascular Renal Metabolic

Heart Failure
Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy

James Burton, Clara Bonanad Lozano, Aaron Wong , et al

Watch time: 1h 3m 30s

Broadcast

Cardiovascular Renal Metabolic

Intervention
Renal Denervation in 2025

Sripal Bangalore, Ajay J Kirtane, Luke Laffin , et al

Watch time: 1h 3m

Broadcast

Cardiovascular Renal Metabolic

Guidelines & Statements
Targeting Residual Inflammatory Risk

Smeeta Sinha, Ramzi Y. J. Khamis, Daniel Bromage , et al

Watch time: 1h 3m 57s

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
The Rise of CVRM Medicine — Your Questions Answered

Neha Pagidipati, Erika SW Jones,

Watch time: 47m 5s

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
The Rise of CVRM Medicine: Managing Common Co-morbidities as One

Neha Pagidipati, Carel Le Roux, Lawrence A Leiter , et al

Watch time: 26s

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Managing Hypertension in CVD: How Low Can We Go?

Yassir Javaid, Michel Burnier, Mariya Tokmakova , et al

Watch time: 57m 24s

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2025 – Day Two

Nisha Bansal, Antonio Ceriello, David Wheeler , et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2025 – Day One

Nisha Bansal, Antonio Ceriello, David Wheeler , et al

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Advancements in Obesity Management (AOM) 2025

Harold Bays, Naveed Sattar, Liesbeth van Rossum , et al

Articles

Targeting Obesity for Heart Failure

Emily Morris

,

Oliver J Rider

,

Published:

23 December 2025

Citation:

European Cardiology Review 2025;20:e38.

DOI:

https://doi.org/10.15420/ecr.2025.37
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 48
  • Read time: 19m 30s

Malnutrition and Prognosis in Elderly Patients with Chronic Heart Failure

Mohammed El-Sheikh

,

Nora Olsen El Caidi

,

Aginsha Kandiah

,

Sandra Henriette Tonning

,

Ida Arentz Taraldsen

,

Frederik Dencker Wisborg

,

Ove Andersen

,

Jens Dahlgaard Hove

,

Johannes Grand

,

Published:

20 October 2025

Citation:

Cardiac Failure Review 2025;11:e26.

DOI:

https://doi.org/10.15420/cfr.2025.31
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 48
  • Read time: 24m 35s

Obesity and CKD: The Dual Epidemic in Cardiovascular Health

Christopher Henry Grant

,

Samira Bell

,

Published:

17 October 2025

Citation:

European Cardiology Review 2025;20:e28.

DOI:

https://doi.org/10.15420/ecr.2025.33
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 79
  • Citations: 1
  • Read time: 19m 2s

Aldosterone Synthase Inhibitors

Shubh K Patel

,

Hwee Teoh

,

Ahreni Saunthar

,

Terrence M Yau

,

Subodh Verma

,

Published:

18 August 2025

Citation:

Cardiac Failure Review 2025;11:e20.

DOI:

https://doi.org/10.15420/cfr.2025.09
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 174
  • Citations: 5
  • Read time: 24m 34s